blisibimod January 19, 2018 blisibimod Trade Name Orphan Indication Patients with immunoglobulin A nephropathy USA Market Approval USA USA Designation Date 2017-08-07 00:00:00 Sponsor Anthera Pharmaceuticals, Inc.;25801 Industrial Boulevard, Suite B;Hayward, California, 94545
